AIM-HI Portfolio Company Profile: Rasio Therapeutics

  • August 10, 2020
  • Blog

Serial entrepreneur Ken Malone, Ph.D., and his team of scientists and business executives are at the forefront of developing cutting-edge biohealth companies. Malone is the Chairman of the Board of Directors of Rasio Therapeutics, a start-up which is bringing innovative…

AIM-HI Portfolio Company Profile: Tvardi Therapeutics

  • July 29, 2020
  • Blog

Imran Alibhai, Ph.D., is the CEO of Tvardi Therapeutics, a biopharmaceutical company developing breakthrough medicines for diverse cancers, chronic inflammatory diseases and fibrotic diseases. The National Foundation for Cancer Research and AIM-HI Accelerator Fund have been early financial supporters of…

AIM-HI Portfolio Company Profile: InterLeukin Combinatorial Therapies

  • July 22, 2020
  • Blog

Paul B. Fisher, M.Ph., Ph.D., co-founded InterLeukin Combinatorial Therapies with hopes of developing a product that destabilizes and kills cancer cells. The Director of Virginia Commonwealth University’s Institute of Molecular Medicine, Fisher represents a world-class scientist with knowledge also of…

Meet Rose Wang

  • July 10, 2020
  • Blog

Rose Wang is a serial entrepreneur who helps other individuals and teams—including female cancer researchers—start their own businesses and make them thrive. Wang is the founder of Binary Group, a consulting and business solutions firm. She also currently serves as Executive…